Zim Laboratories Board of Directors

Get the latest insights into the leadership at Zim Laboratories. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Anwar Daud Chairman & Managing Director
Mr. Prakash Sapkal Director & Head
Mr. Niraj Dhadiwal Director - Business Development
Mr. Zulfiquar M Kamal Director - Finance
Dr. Kakasaheb Mahadik Independent Director
Mrs. Kavita Loya Independent Director
Mr. Padmakar Joshi Independent Director
Dr. Kamlesh Shende Independent Director

Zim Laboratories Share price

ZIMLAB

74.5

1.15 (-1.52%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:53 IST
BUYSELL
Today's High

77.38

Today's Low

73.90

52 Week Low

69.10

52 Week High

128.90

The current prices are delayed, login to your account for live prices

Zim Laboratories FAQs

The board at Zim Laboratories consists of experienced professionals, including Dr. Anwar Daud , Mr. Prakash Sapkal , and others, overseeing the company’s strategic and corporate governance.

Directors at Zim Laboratories are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Anwar Daud is the current chairman at Zim Laboratories.

Executive directors at Zim Laboratories are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Zim Laboratories adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Zim Laboratories, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.